Skip to content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Boronic prodrug of 4-hydroxytamoxifen is more efficacious than tamoxifen with enhanced bioavailability independent of CYP2D6 status

Contributed equally
BMC Cancer201515:625

https://doi.org/10.1186/s12885-015-1621-2

Received: 10 April 2015

Accepted: 21 August 2015

Published: 9 September 2015

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
10 Apr 2015 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
21 Aug 2015 Editorially accepted
9 Sep 2015 Article published 10.1186/s12885-015-1621-2

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
RCMI Cancer Research Center and Department of Chemistry, Xavier University of Louisiana, New Orleans, USA
(2)
Department of Genetics and LSU Stanley Scott Cancer Center, LSU Health Sciences Center, New Orleans, USA

Advertisement